Literature DB >> 28877057

Pleuroparenchymal Fibroelastosis: A Review of Histopathologic Features and the Relationship Between Histologic Parameters and Survival.

Reena Khiroya1, Claudio Macaluso, Maria A Montero, Athol U Wells, Felix Chua, Maria Kokosi, Toby M Maher, Anand Devaraj, Alexandra Rice, Elisabetta A Renzoni, Andrew G Nicholson.   

Abstract

Pleuroparenchymal fibroelastosis (PPFE) is now a defined clinicopathologic entity in the updated 2013 ATS/ERS classification of idiopathic interstitial pneumonias (IIPs), which has led to a significant increase in cases being diagnosed at our institution. We have therefore reviewed 43 PPFE cases (58 biopsies in total) to assess whether any clinical or histopathologic features provide prognostic information. A semiquantatitive grading system was used to assess extent of fibroblastic foci, intra-alveolar fibroelastosis, visceral pleural fibrosis, chronic inflammation in areas of fibrosis, vascular fibrointimal thickening, and presence of granulomas. Other patterns of interstitial lung disease were also noted, if present. All biopsies showed intra-alveolar fibroelastosis, fibroblastic foci at the leading edge of fibrosis and chronic inflammation within areas of fibrosis, 91% showed vascular fibrointimal thickening of vessels, 73% showed pleural fibrosis, and 35% showed granulomas. Ten cases showed a coexistent IIP (5 showed usual interstitial pneumonia, 5 showed features of hypersensitivity pneumonitis). There was no significant correlation with mortality and severity of histologic parameters, other than a significant decrease in mortality in PPFE with coexistent granulomas, after adjusting for age and gender (hazard ratio, 0.27; P=0.049). Male gender was also associated with an increased risk of mortality, after adjusting for age (hazard ratio, 4.8; P=0.045). PPFE is more common than previously thought, not infrequently showing coexistent pathology, specifically usual interstitial pneumonia and granulomatous lung disease, our data suggesting the latter may have prognostic significance.

Entities:  

Mesh:

Year:  2017        PMID: 28877057     DOI: 10.1097/PAS.0000000000000928

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.

Authors:  Yoshiaki Kinoshita; Kentaro Watanabe; Hiroshi Ishii; Hisako Kushima; Makoto Hamasaki; Masaki Fujita; Kazuki Nabeshima
Journal:  Virchows Arch       Date:  2018-10-16       Impact factor: 4.064

Review 2.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

Review 3.  The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Yoshiaki Kinoshita; Hiroshi Ishii; Kazuki Nabeshima; Kentato Watanabe
Journal:  Histol Histopathol       Date:  2020-12-14       Impact factor: 2.303

Review 4.  Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.

Authors:  Felix Chua; Sujal R Desai; Andrew G Nicholson; Anand Devaraj; Elisabetta Renzoni; Alexandra Rice; Athol U Wells
Journal:  Ann Am Thorac Soc       Date:  2019-11

5.  Morphological and molecular motifs of fibrosing pulmonary injury patterns.

Authors:  Danny Jonigk; Helge Stark; Peter Braubach; Lavinia Neubert; Hoen-Oh Shin; Nicole Izykowski; Tobias Welte; Sabina Janciauskiene; Gregor Warnecke; Axel Haverich; Mark Kuehnel; Florian Laenger
Journal:  J Pathol Clin Res       Date:  2019-09-25

6.  Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.

Authors:  Joseph Jacob; Arlette Odink; Anne Laure Brun; Claudio Macaluso; Angelo de Lauretis; Maria Kokosi; Anand Devaraj; Sujal Desai; Elisabetta Renzoni; Athol U Wells
Journal:  Respir Med       Date:  2018-03-30       Impact factor: 3.415

7.  Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis.

Authors:  Sissel Kronborg-White; Claudia Ravaglia; Alessandra Dubini; Sara Piciucchi; Sara Tomassetti; Elisabeth Bendstrup; Venerino Poletti
Journal:  Respir Res       Date:  2018-07-13

8.  Trajectory of lung function to pleuroparenchymal fibroelastosis late after haematopoietic stem-cell transplantation.

Authors:  Giovanni Barisione; Alida Dominietto; Rita Bianchi; Alessandro Garlaschi; Andrea Bacigalupo; Lorenzo Stellino; Vito Brusasco
Journal:  Respir Med Case Rep       Date:  2019-07-27

9.  Idiopathic pleuroparenchymal fibroelastosis confirmed by pathology: a case report.

Authors:  Min Cao; Hui Li; Hou-Rong Cai
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

10.  Pleuroparenchymal fibroelastosis in Korean patients: clinico-radiologic-pathologic features and 2-year follow-up.

Authors:  Jae Ha Lee; Eun Jin Chae; Joon Seon Song; Miae Kim; Jin Woo Song
Journal:  Korean J Intern Med       Date:  2020-02-24       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.